January 9, 2024 · Form 4 insider transaction
GORMAN KEVIN CHARLES bought 62,023 shares of Neurocrine Biosciences, Inc. at $19.59 per share, a transaction worth $1.22M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 1 day after the transaction.